- Report
- March 2024
- 192 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Report
- May 2024
- 193 Pages
Global
From €4756EUR$4,950USD£4,066GBP
- Report
- January 2019
- 317 Pages
Global
From €3842EUR$3,999USD£3,285GBP
- Report
- August 2018
- 98 Pages
Global
From €4756EUR$4,950USD£4,066GBP
- Report
- September 2019
- 188 Pages
Global
From €5717EUR$5,950USD£4,888GBP
- Report
- July 2023
- 98 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Report
- July 2023
- 132 Pages
Global
From €913EUR$950USD£780GBP
The Protein Binding Assay market within the context of Proteomics is a rapidly growing field. It is used to measure the binding of proteins to other molecules, such as DNA, RNA, and other proteins. This type of assay is used to study the structure and function of proteins, as well as to identify potential drug targets. It is also used to study the interactions between proteins and other molecules, such as hormones, enzymes, and other proteins.
The Protein Binding Assay market is driven by the increasing demand for proteomics research and the development of new technologies. The increasing demand for personalized medicine and the development of new drugs are also driving the market.
Companies in the Protein Binding Assay market include Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Agilent Technologies, PerkinElmer, Promega Corporation, and Abcam plc. Show Less Read more